IFF announced the successful completion of the divestiture of its Pharma Solutions business unit to Roquette. This transaction represents a significant milestone for IFF, as it enabled the company to achieve its targeted net debt to credit-adjusted EBITDA of below 3.0x.
The completion of this divestiture is a crucial step in IFF's strategy to focus on its core businesses and capitalize on growth opportunities within its key segments. This strategic move is expected to maximize long-term value for shareholders.
IFF thanked its Pharma Solutions colleagues for their commitment and dedication, wishing them continued success with Roquette. The divestiture reinforces IFF's financial position and enhances its flexibility for future strategic investments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.